These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2881755)

  • 1. The series-compartment model for hepatic elimination.
    Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):27-31. PubMed ID: 2881755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin.
    Pang KS; Gillette JR
    J Pharmacol Exp Ther; 1978 Oct; 207(1):178-94. PubMed ID: 702339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. III. Evaluation of liver models for time-dependent behavior.
    Gray MR; Saville BA; Tam YK
    Drug Metab Dispos; 1987; 15(1):22-6. PubMed ID: 2881754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic elimination kinetics: the influence of hepatic blood flow on clearance determination.
    Keiding S
    Scand J Clin Lab Invest; 1976 Mar; 36(2):113-8. PubMed ID: 1273489
    [No Abstract]   [Full Text] [Related]  

  • 6. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
    Ching MS; Morgan DJ; Smallwood RA
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1048-54. PubMed ID: 2778709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated approach to model hepatic drug clearance.
    Liu L; Pang KS
    Eur J Pharm Sci; 2006 Nov; 29(3-4):215-30. PubMed ID: 16806855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
    Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
    Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow dependence of propranolol elimination in perfused rat liver.
    Keiding S; Steiness E
    J Pharmacol Exp Ther; 1984 Aug; 230(2):474-7. PubMed ID: 6747843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow dependence of metoprolol elimination in isolated perfused rat liver.
    Shen GS; Zhang YD; Li MY; Shen JP
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):430-2. PubMed ID: 7717069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological pharmacokinetic modelling.
    Balant LP; Gex-Fabry M
    Xenobiotica; 1990 Nov; 20(11):1241-57. PubMed ID: 2275217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic galactose elimination kinetics in the intact pig.
    Keiding S; Johansen S; Winkler K
    Scand J Clin Lab Invest; 1982 May; 42(3):253-9. PubMed ID: 7134810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.
    Wagner JG; Szpunar GJ; Ferry JJ
    Drug Metab Dispos; 1984; 12(4):385-8. PubMed ID: 6148202
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of diffusional barriers on drug and metabolite kinetics.
    de Lannoy IA; Pang KS
    Drug Metab Dispos; 1987; 15(1):51-8. PubMed ID: 2881759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
    Chow FS; Piekoszewski W; Jusko WJ
    Drug Metab Dispos; 1997 May; 25(5):610-6. PubMed ID: 9152601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.